rotenone has been researched along with valproic acid in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 5 (55.56) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Adeyeye, MC; Gibbs, JP; Shen, DD; Yang, Z | 1 |
| Jankovic, J; Le, W; Li, X; Pan, T; Xie, W | 1 |
| Lai, JS; Li, PP; Warsh, JJ; Zhao, C | 1 |
| Contestabile, A; Gatta, V; Monti, B; Piretti, F; Raffaelli, SS; Virgili, M | 1 |
| Cao, X; Chen, C; Hou, L; Huang, J; Jia, M; Liang, Z; Lin, Z; Sun, S; Wang, T; Xiong, J; Xiong, N; Yang, H; Zhang, Z | 1 |
| Carriere, CH; Kang, NH; Niles, LP | 1 |
9 other study(ies) available for rotenone and valproic acid
| Article | Year |
|---|---|
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Valproic acid uptake by bovine brain microvessel endothelial cells: role of active efflux transport.
Topics: Adenocarcinoma; Animals; Biological Transport, Active; Brain; Cattle; Cells, Cultured; Cyclooxygenase Inhibitors; Dinitrophenols; Dose-Response Relationship, Drug; Drug Interactions; Endothelial Cells; Fluoresceins; GABA Agents; Humans; Indomethacin; Lung Neoplasms; Multidrug Resistance-Associated Proteins; Pancreatic Neoplasms; Probenecid; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Rotenone; Temperature; Tritium; Uncoupling Agents; Uricosuric Agents; Valproic Acid | 2004 |
Valproic acid-mediated Hsp70 induction and anti-apoptotic neuroprotection in SH-SY5Y cells.
Topics: Apoptosis; Apoptotic Protease-Activating Factor 1; Benzhydryl Compounds; Caspase 3; Caspase 9; Caspases; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Activation; HSP70 Heat-Shock Proteins; Humans; Intracellular Signaling Peptides and Proteins; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Neurons; Neuroprotective Agents; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerases; Precipitin Tests; Proteins; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Pyrrolidinones; Rotenone; Time Factors; Valproic Acid | 2005 |
Cytoprotection by lithium and valproate varies between cell types and cellular stresses.
Topics: Antimanic Agents; Caspase 3; Caspases; Cell Death; Cell Line, Tumor; Cytochromes c; Cytoprotection; Electron Transport Complex I; Endoplasmic Reticulum; Enzyme Activation; Enzyme Inhibitors; Glioma; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Hydrogen Peroxide; Lithium Compounds; Neuroblastoma; Neuroprotective Agents; Oxidative Stress; Proto-Oncogene Proteins c-bcl-2; Rotenone; Thapsigargin; Up-Regulation; Valproic Acid | 2006 |
Valproic acid is neuroprotective in the rotenone rat model of Parkinson's disease: involvement of alpha-synuclein.
Topics: alpha-Synuclein; Analysis of Variance; Animals; Brain; Cell Death; Chromatography, High Pressure Liquid; Disease Models, Animal; DNA Fragmentation; Dopamine; Drug Administration Schedule; Gene Expression Regulation; Histone Deacetylases; Immunoprecipitation; Insecticides; Male; Molecular Weight; Neuroprotective Agents; Parkinson Disease, Secondary; Rats; Rats, Wistar; Rotenone; Valproic Acid | 2010 |
Potential autophagy enhancers attenuate rotenone-induced toxicity in SH-SY5Y.
Topics: Apoptosis; Autophagy; Blotting, Western; Carbamazepine; Cell Line, Tumor; Cell Survival; DNA Fragmentation; Humans; Immunohistochemistry; Membrane Potential, Mitochondrial; Neurons; Neuroprotective Agents; Parkinson Disease; Reactive Oxygen Species; Rotenone; Uncoupling Agents; Valproic Acid | 2011 |
Neuroprotection by valproic acid in an intrastriatal rotenone model of Parkinson's disease.
Topics: Analysis of Variance; Animals; Disease Models, Animal; Dopaminergic Neurons; Functional Laterality; Insecticides; Male; Neuroprotective Agents; Parkinson Disease; Postural Balance; Rats; Rats, Sprague-Dawley; Rotenone; Sensation Disorders; Substantia Nigra; Time Factors; Tyrosine 3-Monooxygenase; Valproic Acid | 2014 |